Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
November 1, 2017
Prothena to Participate in the Credit Suisse 26th Annual Healthcare Conference
DUBLIN, Ireland, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of ...
November 1, 2017
Mirati Therapeutics Reports Third Quarter 2017 Financial Results
SAN DIEGO, Nov. 1, 2017 /PRNewswire/ -- Mirati Therapeutics, Inc. (MRTX), a clinical stage oncology biotechnology company, reported financial results for the third quarter 2017. ...
October 31, 2017
Basilea's Chief Medical Officer Prof. Achim Kaufhold to retire and Dr. Marc Engelhardt named as successor
Basel, Switzerland, October 31, 2017 - Basilea Pharmaceutica Ltd. (SIX:BSLN) reported today that Prof. Achim Kaufhold will retire after seven years with the company. Basilea ...
October 31, 2017
DelMar Pharmaceuticals Presents Data Supporting VAL-083 as a Component of Combination Chemotherapy Regimens for the Treatment of Solid Tumors including Brain and Ovarian Cancer
VANCOUVER, British Columbia and MENLO PARK, Calif., Oct. 31, 2017 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (DMPI) ("DelMar" and "the Company"), a biopharmaceutical company focused on ...
October 31, 2017
Spring Bank Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2017 Financial and Operational Results
HOPKINTON, Mass., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral ...
October 31, 2017
Zogenix to Release Third Quarter 2017 Financial Results and Host Conference Call and Webcast on November 7
EMERYVILLE, Calif., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) ...
October 31, 2017
CymaBay Announces the Appointment of Sujal Shah as President and Chief Executive Officer
NEWARK, Calif., Oct. 31, 2017 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic ...
October 31, 2017
Arcturus Therapeutics and Synthetic Genomics Announce Strategic Alliance to Develop Next-Generation Vaccines and Therapeutics
SAN DIEGO, Oct. 31, 2017 /PRNewswire/ -- Arcturus Therapeutics, Inc., a leading RNA medicines company, and Synthetic Genomics, Inc. announced today that they have entered into ...
October 31, 2017
Minerva Neurosciences Names Dr. Justine Lalonde as Senior Vice President, Product Strategy
WALTHAM, Mass., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ...
October 31, 2017
Arena Pharmaceuticals to Present at the Credit Suisse Healthcare Conference on November 8
SAN DIEGO, Oct. 31, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) today announced that Kevin R. Lind, the Company's Executive Vice President and Chief Financial Officer, ...
October 31, 2017
VBI Vaccines Announces Closing of Public Offering and Concurrent Registered Direct Offering of Common Shares
CAMBRIDGE, Mass., Oct. 31, 2017 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (VBIV) (VBV.TO) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, ...
October 31, 2017
Aimmune Therapeutics Announces Publication in The Journal of Allergy and Clinical Immunology: In Practice of Positive AR101 Data from ARC001 Phase 2 Clinical Trial
BRISBANE, Calif.--(BUSINESS WIRE)-- Aimmune Therapeutics, Inc. (AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies, today announced the online publication of positive data from ...
October 31, 2017
LifeSci Advisors Announces 11th Board Appointment Through Board Placement Initiative
NEW YORK, Oct. 31, 2017 (GLOBE NEWSWIRE) -- LifeSci Advisors, an investor relations and corporate communications firm focused on the life sciences sector, announced today the ...
October 31, 2017
ASPiRA Labs Announces OVA1 Contract with Louisiana Blue Cross Blue Shield
AUSTIN, Texas, Oct. 31, 2017 /PRNewswire/ -- ASPiRA Labs, a Vermillion company (VRML) and exclusive distributor of OVA1 (Multivariate Index Assay, or MIA), an ovarian ...
October 30, 2017
BIOPHYTIS Has FDA Approval to Initiate SARA-INT Phase 2b Interventional Study of Sarconeos in Sarcopenia
PARIS, Oct. 30, 2017 (GLOBE NEWSWIRE) -- BIOPHYTIS (Euronext Growth Paris: ALBPS), a biotechnology company specializing in the development of drug candidates to treat age-related ...
October 30, 2017
Sierra Oncology Reports Preclinical Data for its Chk1 Inhibitor SRA737 Supporting its Ongoing Clinical Development Strategy
VANCOUVER , Oct. 30, 2017 /CNW/ - Sierra Oncology, Inc. (SRRA), a clinical stage drug development company focused on advancing next generation DNA Damage Response ...
October 30, 2017
BioDelivery Sciences to Host Conference Call and Webcast Reporting Third Quarter 2017 Financial Results on November 9
RALEIGH, N.C., Oct. 30, 2017 /PRNewswire/ -- BioDelivery Sciences International, Inc. (BDSI) announced that it will report its third quarter 2017 financial results and host ...
October 30, 2017
Aptose Enters into $15.5 Million Common Shares Purchase Agreement with Aspire Capital Fund, LLC
SAN DIEGO and TORONTO, Oct. 30, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (APTO) (APS.TO), a clinical-stage company developing highly differentiated ...
October 30, 2017
VBI Vaccines Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares and Upsized Registered Direct Offering for Aggregate Proceeds of $71.9 Million
CAMBRIDGE, Mass., Oct. 30, 2017 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (VBIV) (VBV.TO) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, ...
October 30, 2017
Arena Pharmaceuticals to Release Third Quarter 2017 Financial Results and Provide Corporate Update on Tuesday, November 7
SAN DIEGO, Oct. 30, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA), today announced that the Company will release its third quarter 2017 financial results and provide ...
Page 119 of 153